Brief: Carlyle Group Reports 8.1% Stake In Soleno Therapeutics As Of Oct 8 Versus 9.9% As Of Sept 6- SEC Filing
10/10/2024 21:50
Carlyle Group Inc CG.O :
* CARLYLE GROUP REPORTS 8.1% STAKE IN SOLENO THERAPEUTICS AS
OF
OCT 8 VERSUS 9.9% AS OF SEPT 6- SEC FILING
Source text for Eikon: ID:n0001193125-24-235950
Further company coverage: CG.O
Recent news on Soleno Therapeutics
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: EMA's CHMP Recommends Granting A Marketing Authorisation For Cenrifki (Tolebrutinib)